S. Christopher Bauer
30Patents
11h-index
22Co-inventors
67Inventor score
Filing activity: Feb 4, 1994 → Feb 22, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5997860A | Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines | Chemistry; Metallurgy | 60 | Expired |
| US5858347A | Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors | Emerging Cross-Sectional Technologies | 47 | Expired |
| US6030812A | Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors | Chemistry; Metallurgy | 30 | Expired |
| US6440407B1 | Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5772992A | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors | Chemistry; Metallurgy | 21 | Expired |
| US6361977B1 | Methods of using multivariant IL-3 hematopoiesis fusion protein | Chemistry; Metallurgy | 19 | Expired |
| US5604116A | Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5738849A | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5677149A | Interleukin-3 (IL-3) mutant polypeptides and their recombinant production | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6022535A | Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors | Chemistry; Metallurgy | 13 | Expired |
| US5817486A | Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6074639A | Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6057133A | Multivariant human IL-3 fusion proteins and their recombinant production | Chemistry; Metallurgy | 11 | Expired |
| US6066318A | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors | Chemistry; Metallurgy | 11 | Expired |
| US6017523A | Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6051217A | Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6060047A | Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production | Human Necessities | 9 | Expired |
| US6093395A | Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production | Human Necessities | 8 | Expired |
| US6153183A | Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production | Human Necessities | 8 | Expired |
| US6132991A | Human interleukin-3 (IL-3) variant fusion proteins | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6730303B1 | Fused G-CSF and IL-3 proteins and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US6479261B1 | Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6413509B1 | Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors | Chemistry; Metallurgy | 0 | Expired |
| US7091319B1 | IL-3 variant hematopoiesis fusion protein | Chemistry; Metallurgy | 0 | Expired |
| US5997857A | Co-administration of interleukin-3 mutants with colony stimulating factors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.